🟡 Preliminary Evidence
Minerals are fundamental to brain function, yet their role in neurological health remains underappreciated in clinical practice and public health messaging. From chromium’s regulation of insulin sensitivity in neural tissue to lithium’s promotion of neuroplasticity, trace elements orchestrate the biochemical processes that underpin cognition, mood stability, and neuronal resilience. Even mild deficiencies in these micronutrients can produce measurable changes in neurotransmission, cognitive performance, and mental health outcomes.
Key takeaways
- Chromium supports neurotransmitter synthesis and modulates serotonin receptor sensitivity, with evidence from studies of chromium picolinate in atypical depression
- Copper and zinc work synergistically to regulate synaptic signaling and GABA balance, and imbalances have been linked to anxiety and learning difficulties
- Iodine deficiency during pregnancy remains a leading preventable cause of cognitive impairment worldwide, according to endocrinology literature
- Iron is essential for dopamine and serotonin synthesis; low ferritin is associated with fatigue and cognitive impairment that may improve with supplementation
- Lithium promotes neuroplasticity through brain-derived neurotrophic factor (BDNF) release and is established as a mood-stabilizing psychiatric medication
Five minerals essential to brain function and their primary neurological roles
Key mechanisms by which micronutrients support neurotransmission, neuroplasticity, and antioxidant defense
Source: Neurological literature synthesis | Georgian Medical Journal News
Chromium: insulin sensitivity and mood regulation in the brain
Chromium enhances insulin signaling in neural tissue through glucose transporter 4 (GLUT-4) pathways, facilitating glucose uptake essential for neuronal energy metabolism. Beyond glucose handling, chromium modulates serotonin receptor sensitivity, which influences appetite regulation and mood stability. Research on chromium picolinate supplementation in atypical depression has documented improvements in carbohydrate cravings and mood balance, though effect sizes remain modest and further randomized controlled trials are needed.
The mechanism appears to involve both direct neurochemical effects and indirect metabolic stabilization; dysregulated glucose metabolism itself can impair cognitive function and emotional regulation. Clinical applications remain limited, and chromium supplementation is not standard psychiatric practice outside specialized contexts. Recent clinical updates continue to emphasize dietary sources (broccoli, whole grains, nuts) as the primary approach for most populations.
Copper and zinc: synaptic balance and the excitatory-inhibitory axis
Copper and zinc operate as cofactors in multiple neurotransmitter systems, jointly regulating the delicate balance between excitatory (glutamate) and inhibitory (GABA) signaling. Copper is particularly important in cytochrome c oxidase activity and dopamine synthesis, while zinc stabilizes GABA receptors and modulates N-methyl-D-aspartate (NMDA) receptor function. Both excess and deficiency of either mineral have been associated with anxiety, learning difficulties, and altered cognitive performance.
The copper-zinc ratio appears clinically significant; imbalance in either direction can disrupt synaptic homeostasis and contribute to neuroinflammation. Recent literature in peer-reviewed neuroscience highlights the challenge of measuring tissue-level copper and zinc status, as serum levels often do not reflect brain bioavailability. This has complicated the translation of mechanistic knowledge into clinical interventions for cognitive or mood disorders.
Iodine: thyroid function and irreversible cognitive impairment
Iodine deficiency remains the world’s leading preventable cause of cognitive impairment, particularly when deficiency occurs in utero or during early childhood. Iodine is essential for synthesis of thyroid hormones (T3 and T4), which regulate cerebral energy metabolism, myelination, and neuronal migration during critical developmental windows. Even subclinical iodine insufficiency during pregnancy can reduce offspring intelligence quotient by measurable amounts, according to epidemiological data from regions with marginal iodine status.
The public health impact is substantial: the World Health Organization estimates that iodine deficiency affects over 2 billion people globally, with particularly high prevalence in low- and middle-income countries. Universal salt iodization programs have reduced the burden significantly in many regions, but coverage remains incomplete. Evidence on maternal nutrition underscores iodine screening during pregnancy as a cost-effective prevention strategy.
Iron and lithium: dopamine synthesis and neuroprotection
Iron serves as a cofactor in tyrosine hydroxylase and tryptophan hydroxylase enzymes, which catalyze the rate-limiting steps in dopamine and serotonin synthesis respectively. Iron is also essential for brain myelination and maintenance of the blood-brain barrier. Low ferritin levels correlate with fatigue, poor concentration, restless legs syndrome, and mood disturbance; iron repletion in deficient individuals often produces measurable cognitive and emotional improvement.
Lithium, while not a classical “deficiency” mineral, is distinct in its established role as a psychiatric medication with pleiotropic neuroprotective effects. Lithium stimulates release of brain-derived neurotrophic factor (BDNF), a growth factor critical for neuronal survival, synaptic plasticity, and cognitive resilience. Lithium also stabilizes neuronal signaling through glycogen synthase kinase-3 (GSK-3) inhibition and other mechanisms. In mood disorders, particularly bipolar disorder, lithium has the strongest evidence base of any psychotropic medication for suicide prevention and long-term relapse reduction. Environmental and dietary lithium exposure (distinct from pharmaceutical doses) has been epidemiologically associated with lower suicide rates in some regions, though confounding remains difficult to exclude.
Iodine deficiency in pregnancy remains the world’s leading preventable cause of cognitive impairment, with the World Health Organization estimating over 2 billion people globally affected by iodine insufficiency.
— World Health Organization, Global Health Observatory
What this means
Frequently asked questions
Can mineral supplements alone treat depression or anxiety?
While minerals like chromium, copper, and lithium play roles in mood regulation, supplements should not replace evidence-based psychiatric treatment. Lithium, in pharmaceutical doses, is a proven mood stabilizer with strong evidence in bipolar disorder; however, it requires careful monitoring. For other minerals, supplementation may support overall neurological health but should be integrated into a comprehensive treatment plan including psychotherapy and, where indicated, conventional medication.
What are the signs of mineral deficiency affecting the brain?
Iron deficiency may present as fatigue, poor concentration, and restless legs syndrome. Iodine deficiency affects thyroid function and can impair cognitive development, particularly in children. Copper or zinc imbalance may manifest as anxiety, learning difficulties, or mood instability. A clinician can assess mineral status through blood testing; however, serum levels do not always reflect brain tissue concentrations, so clinical correlation is essential.
Is it safe to take mineral supplements without medical supervision?
Minerals have narrow therapeutic windows; excess intake can be as harmful as deficiency. Copper toxicity, iron overload, and lithium toxicity are all well-documented clinical problems. Supplementation should ideally follow evidence of deficiency and be monitored by a healthcare provider. Dietary sources remain the safest approach for most individuals, except in cases of documented deficiency or specific medical conditions.
As neuroscience deepens its understanding of the mineral-brain axis, clinical practice must evolve to incorporate micronutrient assessment into standard neurological and psychiatric evaluation. The evidence base for individual minerals varies considerably—from robust data on iodine’s role in cognitive development to emerging research on chromium and mood—but the fundamental importance of mineral homeostasis to neurological function is indisputable. Future research should prioritize longitudinal studies of mineral status and brain outcomes, development of biomarkers that reflect brain tissue mineral availability, and clinical trials of targeted supplementation in well-defined patient populations.
Source: Minerals and the brain: how micronutrients shape neurological function — original health education article
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
